Nuvectis Pharma Inc.

NASDAQ: NVCT · Real-Time Price · USD
6.54
0.40 (6.51%)
At close: Aug 20, 2025, 3:59 PM
6.54
0.00%
After-hours: Aug 20, 2025, 04:10 PM EDT

Nuvectis Pharma Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-19M -22.26M -19.09M -12.89M
Depreciation & Amortization
n/a n/a n/a n/a
Stock-Based Compensation
4.86M 4.71M 1.71M 1.89M
Other Working Capital
2.17M 1.88M -321K -91K
Other Non-Cash Items
n/a -139K -2.43M 307K
Deferred Income Tax
n/a n/a n/a n/a
Change in Working Capital
1.9M 1.74M 3.82M 1.49M
Operating Cash Flow
-12.25M -15.95M -13.56M -9.5M
Capital Expenditures
n/a n/a n/a n/a
Cash Acquisitions
n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a
Other Investing Acitivies
n/a n/a n/a n/a
Investing Cash Flow
n/a n/a n/a n/a
Debt Repayment
n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
-382K 9.8M -4.07M n/a
Financial Cash Flow
11.65M 15.09M 27.81M 15.25M
Net Cash Flow
-593K -867K 14.25M 5.74M
Free Cash Flow
-12.25M -15.95M -13.56M -9.5M